期刊文献+

姜黄素通过调控上皮间质转化抑制乳腺癌侵袭转移的体外研究 被引量:1

Curcumin inhibits invasion and metastasis ability of breast cancer cell MCF-7 through EMT program
暂未订购
导出
摘要 目的:探讨上皮间质转化(EMT)是否参与姜黄素抑制乳腺癌细胞侵袭转移过程。方法:利用不同浓度姜黄素干预脂多糖(LPS)诱导的乳腺癌细胞MCF-7,MTT法检测细胞增殖能力,普通光学显微镜及透射电子显微镜观察细胞形态变化,RT-PCR和Western blot方法分别检测vimentin,E-cadherin表达变化。结果:姜黄素可抑制LPS诱导的乳腺癌细胞MCF-7 EMT的发生,降低LPS诱导的EMT标志物vimentin蛋白的表达,增强E-cadherin的表达,最终导致乳腺癌细胞运动及侵袭能力的降低。结论:姜黄素可以抑制肿瘤细胞侵袭能力,提示EMT程序参与其中,具体分子机制仍需进一步研究。 Objective: To investigate whether EMT is implicated in the anti-invasion and metastasis effects of curcumin on MCF-7 breast cancer ceil line. Methods: MTT was used to de- tect the anti-proliferative effect of curcumin on MCF-7 cell. The morphological changes were de- termined using optical and transmission electron microscopy, respectively. The protein level for vi- mentin, E-cadherin, were analyzed using RT-PCR and Western blotting. Results: Lipopolysaccha- ride(LPS) was used to trigger EMT in MCF-7 breast cancer cell lines and showed that curcumin in- hibited LPS-induced morphological changes, decreased the expression of LPS-induced markers of EMT such as vimentin, and increased the expression of E-cadherin, resulting in the inhibition of in vitro cell motility and invasiveness. Conclusion: These data provide a new perspective of the an- ti-invasion mechanism of curcumin, indicating that the effect is in part due to its ability to attack the EMT process.
出处 《中国现代普通外科进展》 CAS 2014年第11期851-856,共6页 Chinese Journal of Current Advances in General Surgery
关键词 姜黄素 乳腺肿瘤 侵袭 上皮间质化 Curcumin Breast neoplasms linvasion EMT
  • 相关文献

参考文献24

  • 1Beiki 0,Hall P,Ekbom A,et al.Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background:a population-based cohort study[J].Breast Cancer Res,2012,14(1)H5:1-13.
  • 2梁晓玲,王剑,张岩.威海市30岁以上妇女乳腺疾病普查结果分析[J].中国现代普通外科进展,2010,13(10):803-805. 被引量:3
  • 3Malfettone A,Saponaro C,Paradiso A,et al.Peritumoral vascular invasion and NHERFl expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis[J].BMC cancer,2012,12(1):106.
  • 4Ksiazkiewicz M,Markiewicz A,Zaczek AJ.Epithelial-Mesenchymal Transition:A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells[J].Pathobiology,2012,79(4):195-208.
  • 5Pinho SS,Oliveira P,Cabral J,et al.Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial -mesenchymal-epithelial transitions[J].PloS one,2012,7(3):e33191.
  • 6Ivaska J.Vimentin:Central Kub in EMT induction[J].Small Gtpas- es,2011,2(1):51-53.
  • 7Notarbartolo M,Poma P,Perri D,et al.Antitumor effects of curcum- in,alone or in combination with cisplatin or doxorubicin,on human hepatic cancer cells.Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression[J].Cancer letters,2005,224(1):53-65.
  • 8Chua HL,Bhat-Nakshatri P,Clare S E,et al.NF-kB represses E- cadherin expression and enhances epithelial to mesenchymal transi- tion of mammary epithelial cells:potential involvement of ZEB - 1 and ZEB-2[J].Oncogene,2006,26(5):711-724.
  • 9曹锋,李嘉,李非.Notch信号通路与上皮-间质转化关系研究进展[J].中国现代普通外科进展,2013,16(2):138-141. 被引量:1
  • 10Chen M,Chang W,Kuan Y,et al.Resveratrol inhibits LPS-in- duced epithelial -mesenchymal transition in mouse melanoma model[J]. Innate Immunity,2012,18(5):685-693.

二级参考文献55

  • 1赵艳,邹昕,刘富强,刘克俭.1999—2005年武昌车辆厂职工乳腺疾病普查结果分析[J].职业与健康,2007,23(1):39-41. 被引量:10
  • 2Houssami N,Cheung M N,Dixon J M.Fibroadenoma of the breast[J].Med J Aust,2001,174(4):185-188.
  • 3Howe HL,Wingo PA,Thun MJ,et al.Annual report to the nation on the status of cancer(1973 Through 1998),featuring cancers with recent increasing trends[J].J Natl Cancer Inst,2001,93(11):824-842.
  • 4Nawshad A,Lagamha D,Polad A,et al. Transforming growth factor-β signaling during epithelial- mesenchymal transforation : Implication for emhryogenesis and tumor metastasis [J]. Cells Tissues Organs, 2005,179 (1) : 11 - 23.
  • 5Thiery JP. Epithelial-mesenchymal transitions in tumor progression [J]. Nat Rev Cancer, 2002, 2(6): 442-454.
  • 6Matsumura T,Makino R,Mitamura K,et al. Frequent down-regulation of E-cadeherin by genetic and epigenetic changes in the malignant progress of hepatocellular carcinomas [J]. Clin Cancer Res, 2001, 7(3) :594-599.
  • 7Eger A, Stockinger A,Schaffhauser B, et al. Epithelial mesenchymal transition by c-los estrogen receptor activation involves nuclear translocation of β-catenin and upregulation of β-catenin/lymphoid enhancer binding factor-1 transcriptional activity [J]. Cell Biol, 2000,148 (1) : 173-188.
  • 8Kotoh M. Epithelial-mesenchymal transition in gastric cancer [J]. Int J Oncol, 2005,27 (6) : 1677-1683.
  • 9Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail,sipl,and twist in gastric cancer [J]. AMJ Pathol, 2002,161 (5) : 1881 - 1891.
  • 10Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA dependent mechanism [J]. Mol Biol Cell, 2001,12 (1) : 27-36.

共引文献11

同被引文献60

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部